2024-11-20 11:44:41
Gannex Announces the First Cohort Dosed in a U.S. Clinical Study with THR-β Agonist ASC41
Corporate/ 2023-07-23
Gannex Announces the First Cohort Dosed ...

SHANGHAI,April 14,2021-- Gannex,a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672),fully dedicated to the R&D and commercializa...

BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology
Corporate/ 2023-07-23
BioVaxys Announces Final Clinical trial ...

VANCOUVER,BC,April 14,2021--BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:LMNGF)("BioVaxys"),the world leaderin haptenized ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release